Micron is reportedly increasing production capacity of a more profitable memory offering that’s in high demand due to AI.

While there are long-term debates around Oracle’s stock, analysts say the company looks poised to benefit from upbeat pricing ...

After getting passed over for several quarters, Bloom Energy is finally getting a spot in the S&P 500.

The Food and Drug Administration approved an AstraZeneca-made treatment for advanced breast cancer. The agency on Friday said it granted accelerated approval for Etcamah, known generically as ...

The stock's fall snapped a two-day winning streak. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the ...

This was the stock's third consecutive day of gains.

This was the stock's second consecutive day of gains.

This was the stock's second consecutive day of gains. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the ...

Among FTSE 100 constituents, finance companies company Experian PLC EXPN -4.38% saw the largest decrease Friday, as shares shed 4.38% ...

The SPDR Select Sector Utilities exchange-traded fund, which tracks the utilities industry group of the S&P 500 is down slightly for the year to date. Rising Treasury yields have overshadowed the ...

ADARx focuses on siRNA therapeutics and has five programs in its pipeline addressing several indications, including obesity, Alzheimer's disease, and strokes, according to the filing. The company said ...

This was the stock's third consecutive day of gains.